SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-19-000023
Filing Date
2019-08-06
Accepted
2019-08-06 07:11:45
Documents
16
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-q2x2019pressrelease.htm   iXBRL 8-K 43818
2 EXHIBIT 99.1 ex991-q2x2019.htm EX-99.1 933686
8 bauschlogoa02.jpg GRAPHIC 7860
  Complete submission text file 0000885590-19-000023.txt   1182573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20190806.xsd EX-101.SCH 4570
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20190806_cal.xml EX-101.CAL 614
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20190806_def.xml EX-101.DEF 1464
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20190806_lab.xml EX-101.LAB 27205
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20190806_pre.xml EX-101.PRE 14089
9 EXTRACTED XBRL INSTANCE DOCUMENT a8k-q2x2019pressrelease_htm.xml XML 4707
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 191000409
SIC: 2834 Pharmaceutical Preparations